Making Chemically Defined Media Work
BioPharm International-11-01-2010
Best practices to strengthen supplier quality management.
The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?
Adequate characterization of materials protects product quality.
These new analytical methods can reduce analysis and product development time.
Comparative effectiveness poses challenges for drug manufacturers.
China's regulators acknowledge the quality gap, and have a plan for steady improvement.
Advertisement
Advertisement
Trending on BioPharm International
1
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
2
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
3
FAQ: When Big Pharma Drops a Drug Candidate, Who Picks It Up?
4
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
5